cardiogenesis.com Pages on BioPortfolio:

BioPortfolio - CardioGenesis Corporation - Profile
View the current CardioGenesis Corporation Page on BioPortfolio.com ... Cardiogenesis Corporation to Report Third Quarter 2008 Results on November 13th
...
http://www.bioportfolio.com/biocorporate/2429-CardioGenesis%...

Biotechnology News Angina Search
13 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation , a leading developer of surgical products used in the treatment of patients suffering from severe ...
http://www.bioportfolio.co.uk/Angina-news.htm...

BioPortfolio - Biocorporate Search Medical Device
CardioGenesis Corporation. Global leader in TMR and PMR (International markets only) An innovative and leading angiogenesis device company providing ...
http://www.bioportfolio.com/biocorporate/Medical%20Device-co...

Biotechnology News Antiphospholipid iga. elisa. titr. igm. ab. pt ...
Ten-year trends in the incidence and treatment of cardiogenic shock Rates of overall cardiogenic shock (8.3% of ACS pts) and cardiogenic shock during ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Intra-Aortic Balloon Pumping
Percutaneous ventricular assist devices for cardiogenic shock. ... Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-Aortic Balloon ...
http://www.bioportfolio.com/indepth/Intra-Aortic_Balloon_Pum...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
Cardiogenesis Reports Third Quarter 2008 Results. KSLA: similar ... Cardiogenesis Reports Third Quarter 2008 Results ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Congestive Heart Failure: Major World Markets, Volume II: Devices ...
... Inc. Cardiac Science Corporation; Cardiogenesis Corporation; Cordis Corporation/Biologics Delivery Systems; CoreValve, Inc. CryoCath Technologies,
Inc. ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1030.html...

BioPortfolio.com - BioWeb Pulmonary Edema Search
Noninvasive PSV May Obviate ICU Admission for Cardiogenic Pulmonary Edema ... A Ventilator Protocol for Fulminating Non-Cardiogenic Pulmonary Edema ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Congestive Heart Failure: Major World Markets, Volume II: Devices ...
Cardiogenesis Corporation. Cordis Corporation/Biologics Delivery Systems. CoreValve, Inc. CryoCath Technologies, Inc. Cryocor, Inc. Datascope ...
http://www.bioportfolio.com/cgi-bin/acatalog/Congestive_Hear...

BioPortfolio.com - BioWeb Syncope Fainting Search
Self Help Clearinghouse Neuro-Cardiogenic Syncope This information is provided as a resource and does not constitute an endorsement for any group. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

Results from other life science and pharmaceutical sites:

CardioGenesis and PLC Settle Patent Dispute
Under the Settlement and License Agreement signed by the parties today, PLC grants CardioGenesis a non-exclusive worldwide license to the PLC patents. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Cardiogenesis Corporation Announces Preliminary Clinical Results ...
Dr. Reyes reports on the use of the PHOENIX system, a Holmium YAG Laser TMR and biologic combination delivery system manufactured by Cardiogenesis. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=100140...

Cardiogenesis Reports Third Quarter 2008 Results
13 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a leading developer of surgical products used in the treatment of patients ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus....

Cardiogenesis Corporation Receives FDA Approval for PEARL 5.0 ...
"The Cardiogenesis TMR system uses laser energy delivered through a small optical fiber to create channels in heart muscle that doesn't have enough blood
...
http://www.biospace.com/news_story.aspx?NewsEntityId=77239...

CardioGenesis Completes Phase II Axcis PMR Randomized Trial
CardioGenesis is currently conducting three, six and twelve month patient follow -ups with the primary study outcome measures being reduction in angina class ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Cardiogenesis Corporation Reports Third Quarter 2008 Results ...
13 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation , a leading developer of surgical products used in the treatment of patients suffering from severe ...
http://www.biospace.com/news_story.aspx?NewsEntityId=117389...

CardioGenesis Reports Results for the First Quarter Ended March 31 ...
"We continue to make significant progress in both the areas of ITMR and PMR," commented Allen W. Hill, CardioGenesis President and CEO. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

CardioGenesis Corporation Announces Update On Minimally Invasive ...
On April 25, 2006, Louis A. Brunsting, III, M.D., Centennial Medical Center in Nashville, Tennessee, presented his findings on the Cardiogenesis PEARL 5.0 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=16677...

CardioGenesis Comments on Blue Cross Blue Shield Association TEC ...
"This is a further validation of this therapy and a positive result for the reimbursement efforts undertaken by CardioGenesis and other companies ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Cardiogenesis Announces Successful Educational Symposium Targeted ...
Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, DC. - IRVINE, Calif., Oct. 14
...
http://biz.yahoo.com/prnews/081014/latu034.html?.v=101...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.